Preview

Pharmacokinetics and Pharmacodynamics

Advanced search

Examine the pharmacokinetics of three formulations of the drug for regenerative gene therapy damage the surface of human tissues of various etiologies

Abstract

The purpose of this study was to compare the pharmacokinetic and pharmacodynamic parameters of three formulations of a new drug on the basis of plasmid DNA pCIGF for regenerative gene therapy damage the surface of human tissues of various etiologies. Preclinical study of the pharmacological properties of the drug and drug safety carried out in mice, which was administered once and twice. Introduction of liquid and lyophilized forms of the drug was carried out by intramuscular injection, topically applied gel form. Analyzed various organs: brain, heart, blood, lung, liver, kidney, spleen, muscle for the presence of plasmid depending on the time after administration.

About the Authors

I. V. Duhovlinov
LLC «Pharma Gen»
Russian Federation


R. I. Al-Shekhadat
LLC «Pharma Gen»
Russian Federation


A. I. Orlov
FGBI «Scientific Research Institute of Experimental Medicine» RAMS, St. Petersburg
Russian Federation


References

1. Каркищенко Н.Н., Хоронько В.В., Сергеева С.А., Каркищенко В.Н. Фармакокинетика. Феникс, Ростов-на-Дону. 2001.

2. Демографическая политика Российской Федерации на период до 2025 года. // Программа Министерства труда и социальной защиты РФ от 13.11.2012г. (информация взята с сайта Министерства труда и социальной защиты РФ http://www.rosmintrud.ru/ministry/ programms/6).

3. Bonadio J., Smiley E., Patil P., Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. // Nature Medicine 1999. Vol. 5. P. 753—759.

4. Horn N., Meek J., Budahazi G., Marquet M. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. // Hum Gene Therapy. 1995. Vol. 6. P. 565—573.


Review

For citations:


Duhovlinov I.V., Al-Shekhadat R.I., Orlov A.I. Examine the pharmacokinetics of three formulations of the drug for regenerative gene therapy damage the surface of human tissues of various etiologies. Pharmacokinetics and Pharmacodynamics. 2013;(1):35-39. (In Russ.)

Views: 522


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7836 (Print)
ISSN 2686-8830 (Online)